Hikma Pharmaceuticals USA has started work on a $1 billion investment that includes an expansion of its West Side facilities.
The company, a division of London-based Hikma, officially broke ground over the weekend on the expansion of its facility at 1809 N. Wilson Rd. The 130,000-square-foot addition will expand the facility’s research and development and manufacturing capabilities.
The West Side plant is the largest U.S. manufacturing center for Hikma, which makes generic drugs. The Columbus facility, which employs more than 1,300 workers, produces a range of drugs, including generic versions of the asthma drug Advair and the allergy inhaler Flonase…